In this study, an increase in PRDX6 was observed in SLE and LN, suggesting a predominant inflammatory response through the elevated oxidative stress-mediated signaling pathway, which is consistent with findings in some autoimmune diseases (21, 29, 30). This evidence concerns the gene PRDX6 and systemic lupus erythematosus.